Opus Genetics Inc
(IRD)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2011 | 09-2011 | 06-2011 | 03-2011 | 12-2010 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -11,345 | -11,734 | -10,265 | -4,436 | -14,022 |
| Depreciation Amortization | -50 | -36 | -23 | -10 | -44 |
| Other Working Capital | -117 | 2,477 | 2,437 | 1,246 | 528 |
| Other Operating Activity | -4,019 | -1,358 | 361 | 774 | 6,551 |
| Operating Cash Flow | $-15,530 | $-10,652 | $-7,491 | $-2,426 | $-6,987 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 500 | 500 | 500 | N/A | -2,279 |
| PPE Investments | -16 | -4 | -2 | N/A | -5 |
| Other Investing Activity | -1,030 | -2,546 | -2,776 | -2,958 | 1,624 |
| Investing Cash Flow | $-546 | $-2,050 | $-2,278 | $-2,958 | $-660 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 13,598 | 13,578 | 13,556 | 13,556 | 12,689 |
| Financing Cash Flow | $13,598 | $13,578 | $13,556 | $13,556 | $12,689 |
| Beginning Cash Position | 12,340 | 12,340 | 12,340 | 12,340 | 7,298 |
| End Cash Position | 9,862 | 13,217 | 16,128 | 20,513 | 12,340 |
| Net Cash Flow | $-2,479 | $877 | $3,788 | $8,173 | $5,042 |
| Free Cash Flow | |||||
| Operating Cash Flow | -15,530 | -10,652 | -7,491 | -2,426 | -6,987 |
| Capital Expenditure | -16 | -4 | -2 | N/A | -5 |
| Free Cash Flow | -15,546 | -10,656 | -7,493 | -2,426 | -6,992 |